MedTrace Logo

Wound Infiltration as Part of an Opioid Free Pain Management Pathway Following Cesarean Delivery

NCT03545516 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 540

Last updated 2018-08-29

No results posted yet for this study

Summary

This study will investigate the effect of three types of wound infiltration on post Cesarean opioid analgesia consumption when used in conjunction with an opioid free postoperative analgesia pathway.

Conditions

  • Pain, Postoperative
  • Anesthesia, Local
  • Opioid Use

Interventions

DRUG

Bupivacaine

Injection of bupivacaine into the surgical incision prior to its closure.

DRUG

Dexmedetomidine

Injection of dexmedetomidine ( an adjuvant) into the surgical incision prior to its closure.

DRUG

Placebo

Injection of a placebo into the surgical wound

Sponsors & Collaborators

  • Richmond University Medical Center

    lead OTHER

Principal Investigators

  • Nisha Lakhi, MD · Richmond University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-17
Primary Completion
2018-11-01
Completion
2018-11-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03545516 on ClinicalTrials.gov